The report "Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027", for Plasma Fractionation is projected to reach USD 711 million by 2027 from USD 569 million in 2022, at a CAGR of 4.5% during the forecast period. Factors such as the rising zoonotic disease concerns, Rising use of immunoglobulins and other plasma products in a range of therapeutic areas and Increasing demand for Plasma-derived medicinal products driving the growth of the Cold Chain Products Market for Plasma Fractionation. However, shortage of trained manpower & limited resources to maintain the equipment and Environmental concerns regarding greenhouse gas emissions will be challenges in the growth of this market during the forecast period.
Browse 120 market data Tables and 50 Figures spread through 200 Pages and in-depth TOC on "Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cold-chain-product-market-159802939.html
In this report, the Cold Chain Products Market for Plasma Fractionation is segmented based on type, end user, and region.
"Temperature monitoring devices segment is expected to witness the fastest growth in the forecast period.”
The Cold Chain Products for Plasma Fractionation market is categorized into seven types, including Ultra-low temperature freezers, Plasma freezers, Temperature monitoring devices, Plasma contact shock freezers, Blood transport boxes, Ice-lined refrigerators, and Others. Among these categories, the Temperature monitoring devices segment is projected to experience the highest growth rate from 2022 to 2027. Increased research and development investment in medical devices such as medical freezers and refrigerators are additional factors that are anticipated to drive market growth during the forecasted period
"Blood collection centers and blood component providers accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021."
The Cold Chain Products Market for Plasma Fractionation is categorized into different end users, including Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others. Among these, the Blood collection centers, and blood component providers segment held the fastest-growing market for cold chain products for plasma fractionation in 2021. This significant market share can be attributed to factors such as the increasing prevalence of diseases like hemophilia, immune deficiency disorders, and liver diseases, as well as the growing aging population.
"North America accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021"
The Cold Chain Products Market for Plasma Fractionation is segmented into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America emerged as the dominant market for Cold Chain Products for Plasma Fractionation worldwide. The increasing demand for plasma freezers and the availability of advanced cold storage devices for laboratories are expected to be major driving factors for market growth in North America. The region's substantial market share can be attributed to its well-developed healthcare infrastructure and the continuous investment in research and development of medical devices such as medical freezers and refrigerators.
Key Market Players :
The prominent players in the global Cold Chain Products Market for Plasma Fractionation are B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
Don’t miss out on business opportunities in Cold Chain Products Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441